Category Archives: Orthopedics

SGR specter haunts AAOS 2015 conference

The Las Vegas casinos were teeming with activity last week, but the true bets from orthopedic surgeons who descended upon the city during the American Academy of Orthopedic Surgeons (AAOS) weren’t originating from the tables in their hotel lobbies. Smart…

FacebookTwitterGoogle+Share

Stryker S&N acquisition rumors bolster recent orthopedic space consolidation

While orthopedic implant maker Stryker (Kalamazoo, Michigan) said today that  it did not intend to make an offer for Smith & Nephew (S&N; London) after a report in the Financial Times forced its hand, it seems likely that such a…

FacebookTwitterGoogle+Share

Enough stinky greens, med-tech wants dessert!

Change is what the American public was promised (or some might say threatened with) during the 2008 presidential election and for better or worse, the healthcare industry worldwide has been served an extra large helping of that change over the…

FacebookTwitterGoogle+Share

Sundays with Peyton now not a pain in the neck

It is fall here in the U.S. and, for many Americans, that time of year brings cooler weather and football. Apologies to our non-U.S. readers, I realize that you have ownership on “real” football, and our version is secular at…

FacebookTwitterGoogle+Share

Gigantic jury award in first J&J hip implant case is breathtaking as an initial benchmark

Chilling. It isn’t often that a bit of news is a perfect fit to that one-word description, but the recent decision by a Los Angeles jury in the first case to be decided pitting Johnson & Johnson (J&J; New Brunswick,…

FacebookTwitterGoogle+Share

SpinalCyte solution could shape biologics future

Recently, I had the opportunity to interview Pete O’Heeron, CEO of a private company called SpinalCyte, a company developing an application to treat degenerative disc disease using cells derived from human skin for the Nov. 9th edition of Medical Device…

FacebookTwitterGoogle+Share

Simplicity beats bells and whistles

I have been reporting medical technology news for close to six years and one thing that has consistently amazed me during that time has been the fact that simplicity often beats bells and whistles. The most recent example of this is…

FacebookTwitterGoogle+Share

Could Medtronic eventually shed Infuse?

After Johnson & Johnson (J&J, New Brunswick, New Jersey) said that it was going to discontinue its work in the drug eluting stent (DES) market, my eyes then began to focus on Medtronic (Minneapolis), which has recently taken a beating…

FacebookTwitterGoogle+Share

Is Medtronic’s cancellation of GPO contracts a prelude to a trend, or just an anomaly?

Late last month, Medtronic (Minneapolis) reported that it was cancelling several of its largest contracts with group purchasing organizations (GPOs) worth more than $2 billion collectively. Medtronic said the decision to cancel five contracts with Novation (Irving, Texas) and another…

FacebookTwitterGoogle+Share

Marketo